{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Dennis Kappei"}, {"accession": "MS:1000589", "name": "contact email", "value": "dennis.kappei@nus.edu.sg"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Cancer Science Institute of Singapore"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Dennis Kappei"}, {"accession": "MS:1000589", "name": "contact email", "value": "dennis.kappei@nus.edu.sg"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Cancer Science Institute of Singapore (CSI), National University of Singapore (NUS)"}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014736/SMURF2_txt.zip"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014736/20151116_QPC_DK_CSI_Eichhorn_Scr_for.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014736/20151116_QPC_DK_CSI_Eichhorn_Scr_rev.raw"}], "description": "Treatment of muscle-invasive bladder cancer remains a major clinical challenge. Aberrant HGF/c-MET upregulation and activation is frequently observed in bladder cancer correlating with cancer progression and invasion. However, the precise mechanisms underlying HGF/c-MET mediated invasion in bladder cancer remains unknown. As part of a negative feedback loop SMAD7 binds to the E3 ligase SMURF2 targeting the TGF\u03b2 receptor for degradation. Under these conditions SMAD7 acts as an agonist disrupting the intermolecular interactions within SMURF2, permitting SMURF2 activation. We demonstrate that HGF stimulates TGF\u03b2 signaling by inducing c-SRC mediated phosphorylation of SMURF2 at two tyrosine residues impeding SMAD7 binding and enhancing SMURF2 C2-HECT domain interaction, resulting in SMURF2 inhibition and TGF\u03b2 receptor stabilization. This upregulation of the TGF\u03b2 pathway by HGF leads to TGF\u03b2-mediated EMT and invasion. Using biologically relevant orthotopic mouse models we show that inhibition of TGF\u03b2 signaling completely prevents HGF induced bladder cancer invasion. Furthermore, we make a rationale for the use of TGF\u03b2 receptor and MEK inhibitors in the treatment of high grade non-muscle-invasive bladder cancers or early stage muscle invasive bladder cancers.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014736"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD014736"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD014736"}], "instruments": [{"accession": "MS:1002523", "name": "Q Exactive HF"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Bladder cancer invasion, EMT, c-MET,  TGFB, SMURF2, phosphorylation"}], "modifications": [{"accession": "MOD:00587", "name": "6x(13)C", "value": "4x(15)N labeled L-arginine"}, {"accession": "MOD:00582", "name": "6x(13)C", "value": "2x(15)N labeled L-lysine"}, {"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "PRIDE:0000432", "name": "Dataset with its publication pending"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "c-Met activation leads to the establishment of a TGF\u03b2 receptor regulatory network required for bladder cancer invasion"}